Variant report
Variant | esv2760278 |
---|---|
Chromosome Location | chr13:96920844-96924615 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs575378323 | chr13:96920889-96920890 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs115072016 | chr13:96920892-96920893 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs533244527 | chr13:96920906-96920907 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs74988256 | chr13:96920948-96920949 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs142866526 | chr13:96921021-96921022 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs1927794 | chr13:96921049-96921050 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
7 | rs535653098 | chr13:96921078-96921079 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs555651072 | chr13:96921083-96921084 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs371954460 | chr13:96921088-96921089 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs563506167 | chr13:96921150-96921151 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs550988681 | chr13:96921176-96921177 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs565998552 | chr13:96921244-96921245 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs189874716 | chr13:96921256-96921257 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs557449690 | chr13:96921267-96921268 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs141526878 | chr13:96921279-96921280 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs9554332 | chr13:96921283-96921284 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
17 | rs1927793 | chr13:96921287-96921288 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
18 | rs1927792 | chr13:96921313-96921314 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
19 | rs542041025 | chr13:96921350-96921351 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs1927791 | chr13:96921420-96921421 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
21 | rs9556540 | chr13:96921468-96921469 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
22 | rs541737220 | chr13:96921478-96921479 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs76517824 | chr13:96921503-96921504 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs78885693 | chr13:96921512-96921513 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs530633335 | chr13:96921522-96921523 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs35468816 | chr13:96921527-96921528 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs192136246 | chr13:96921545-96921546 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs570217469 | chr13:96921671-96921672 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs529068201 | chr13:96921711-96921712 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs549186765 | chr13:96921721-96921722 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs565912528 | chr13:96921723-96921724 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs550359325 | chr13:96921749-96921750 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs534611685 | chr13:96921750-96921751 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs558073971 | chr13:96921799-96921800 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs373969521 | chr13:96921832-96921833 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs184551900 | chr13:96921914-96921915 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs60437046 | chr13:96921959-96921960 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs190256744 | chr13:96921988-96921989 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs147121408 | chr13:96922021-96922022 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs75013963 | chr13:96922045-96922046 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs77522735 | chr13:96922047-96922048 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs112298546 | chr13:96922077-96922078 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs138538361 | chr13:96922093-96922094 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs535975266 | chr13:96922123-96922124 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs181832961 | chr13:96922124-96922125 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs115149011 | chr13:96922155-96922156 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs1927790 | chr13:96922191-96922192 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
48 | rs118075018 | chr13:96922210-96922211 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs577909349 | chr13:96922294-96922295 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs186393775 | chr13:96922295-96922296 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Prostate cancer | 16705090 | CNVD |
High-proliferative meningiomas | 17937814 | CNVD |
Cancer | 20164919 | CNVD |
Autism | 22495311 | CNVD |
Chordoma | 21602918 | CNVD |
Bladder cancer | 21949216 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Cancer | 21637783 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Chronic lymphocytic leukemia | 21518781 | CNVD |
colon cancer | 17210682 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Ovarian cancer | 20844748 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Intracranial aneurysm | 19064780 | CNVD |
Breast cancer | 19287154 | CNVD |
Acute myeloid leukemia | 18379011 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Olfactory neuroblastoma | 18408657 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Ependymoma | 16718352 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Colorectal cancer | 16272173 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Breast cancer | 16608533 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Myoepithelioma | 18604193 | CNVD |
Breast cancer | 17133270 | CNVD |
Prostate cancer | 18632612 | CNVD |
Melanoma | 18172304 | CNVD |
Prostate cancer | 16573809 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Gastric cancer | 17908304 | CNVD |
Splenic marginal zone lymphoma | 18492102 | CNVD |
Liposarcoma | 21253554 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Chronic lymphocytic leukemia | 20421269 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Lung cancer | 18438408 | CNVD |
Non-syndromic sensorineural hearing loss | 20606397 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Omodysplasia | 19481194 | CNVD |
Breast cancer | 22032731 | CNVD |
Rhabdomyosarcoma | 17210683 | CNVD |
Wilms tumour | 21544195 | CNVD |
Developmental delay | 21147756 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
Cancer | 21183584 | CNVD |
Breast cancer | 17603634 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Thyroid cancer | 19087340 | CNVD |
abortions and stillbirths | 19751515 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Acute myeloid leukemia | 19651601 | CNVD |
Congenital anomalies of the kidney and urinary tract | 20467480 | CNVD |
Esophageal adenocarcinoma | 18820669 | CNVD |
Burkitt''s lymphoma | 20823134 | CNVD |
Basal cell lymphoma | 21115979 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr13:96918600-96922200 | Weak transcription | Pancreatic Islets | Pancreatic Islet |
2 | chr13:96921800-96925200 | Enhancers | Fetal Intestine Large | intestine |
3 | chr13:96922200-96922600 | Enhancers | Pancreas | Pancrea |
4 | chr13:96922200-96922800 | Enhancers | Pancreatic Islets | Pancreatic Islet |
5 | chr13:96922200-96924800 | Enhancers | Fetal Intestine Small | intestine |
6 | chr13:96922600-96926600 | Weak transcription | Pancreas | Pancrea |
7 | chr13:96922800-96923200 | Weak transcription | Pancreatic Islets | Pancreatic Islet |
8 | chr13:96922800-96924000 | Enhancers | iPS-20b Cell Line | embryonic stem cell |
9 | chr13:96923000-96923400 | Enhancers | H9 Cell Line | embryonic stem cell |
10 | chr13:96923000-96923400 | Enhancers | HUES48 Cell Line | embryonic stem cell |
11 | chr13:96923000-96923400 | Enhancers | HUES64 Cell Line | embryonic stem cell |
12 | chr13:96923000-96923400 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
13 | chr13:96923000-96924000 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
14 | chr13:96923200-96923400 | Enhancers | Pancreatic Islets | Pancreatic Islet |
15 | chr13:96923400-96924200 | Weak transcription | Pancreatic Islets | Pancreatic Islet |
16 | chr13:96924200-96926800 | Enhancers | Pancreatic Islets | Pancreatic Islet |